Equities analysts expect Agilent Technologies, Inc. (NYSE:A) to report earnings per share of $0.52 for the current fiscal quarter, Zacks Investment Research reports. Seven analysts have issued estimates for Agilent Technologies’ earnings. The highest EPS estimate is $0.56 and the lowest is $0.50. Agilent Technologies posted earnings of $0.49 per share during the same quarter last year, which would indicate a positive year-over-year growth rate of 6.1%. The business is scheduled to report its next quarterly earnings report after the market closes on Tuesday, August 15th.
On average, analysts expect that Agilent Technologies will report full-year earnings of $2.22 per share for the current financial year, with EPS estimates ranging from $2.18 to $2.29. For the next year, analysts anticipate that the business will report earnings of $2.53 per share, with EPS estimates ranging from $2.43 to $2.80. Zacks Investment Research’s EPS averages are a mean average based on a survey of research analysts that cover Agilent Technologies.
Agilent Technologies (NYSE:A) last posted its earnings results on Monday, May 22nd. The medical research company reported $0.58 EPS for the quarter, beating analysts’ consensus estimates of $0.48 by $0.10. The business had revenue of $1.10 billion for the quarter, compared to the consensus estimate of $1.05 billion. Agilent Technologies had a net margin of 13.41% and a return on equity of 16.49%. The company’s revenue for the quarter was up 8.1% on a year-over-year basis. During the same quarter last year, the firm posted $0.44 EPS.
Several analysts have recently issued reports on A shares. Deutsche Bank AG reissued a “buy” rating and set a $66.00 price target on shares of Agilent Technologies in a research report on Thursday, June 22nd. BidaskClub lowered shares of Agilent Technologies from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, June 13th. BTIG Research upped their target price on shares of Agilent Technologies from $57.00 to $65.00 and gave the stock a “buy” rating in a research note on Wednesday, May 24th. Zacks Investment Research upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating and set a $63.00 target price on the stock in a research note on Tuesday, May 16th. Finally, Jefferies Group LLC upped their target price on shares of Agilent Technologies from $59.00 to $66.00 and gave the stock a “buy” rating in a research note on Tuesday, May 23rd. Two analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company. The stock currently has an average rating of “Buy” and an average price target of $60.12.
In other news, insider Patrick Kaltenbach sold 5,000 shares of the firm’s stock in a transaction that occurred on Thursday, May 4th. The shares were sold at an average price of $56.50, for a total transaction of $282,500.00. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Michael R. Mcmullen sold 32,511 shares of the firm’s stock in a transaction that occurred on Monday, May 1st. The stock was sold at an average price of $55.48, for a total transaction of $1,803,710.28. Following the transaction, the chief executive officer now owns 260,346 shares in the company, valued at $14,443,996.08. The disclosure for this sale can be found here. Insiders sold 150,119 shares of company stock worth $8,823,719 over the last quarter.
Several institutional investors have recently made changes to their positions in the company. Fox Run Management L.L.C. raised its position in shares of Agilent Technologies by 111.0% in the first quarter. Fox Run Management L.L.C. now owns 21,947 shares of the medical research company’s stock worth $1,160,000 after buying an additional 11,547 shares during the period. Private Trust Co. NA raised its position in shares of Agilent Technologies by 2.1% in the first quarter. Private Trust Co. NA now owns 7,660 shares of the medical research company’s stock worth $404,000 after buying an additional 161 shares during the period. Capstone Asset Management Co. raised its position in shares of Agilent Technologies by 7.4% in the first quarter. Capstone Asset Management Co. now owns 43,126 shares of the medical research company’s stock worth $2,280,000 after buying an additional 2,990 shares during the period. Quadrant Capital Group LLC raised its position in shares of Agilent Technologies by 0.9% in the first quarter. Quadrant Capital Group LLC now owns 5,470 shares of the medical research company’s stock worth $284,000 after buying an additional 50 shares during the period. Finally, Gulf International Bank UK Ltd raised its position in shares of Agilent Technologies by 3.7% in the first quarter. Gulf International Bank UK Ltd now owns 101,706 shares of the medical research company’s stock worth $5,377,000 after buying an additional 3,600 shares during the period.
Agilent Technologies (NYSE A) opened at 61.37 on Monday. The stock has a market cap of $19.72 billion, a P/E ratio of 34.50 and a beta of 1.31. Agilent Technologies has a 52-week low of $42.92 and a 52-week high of $61.84. The firm’s 50-day moving average is $60.03 and its 200-day moving average is $54.38.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 26th. Shareholders of record on Monday, July 3rd will be paid a $0.132 dividend. The ex-dividend date is Thursday, June 29th. This represents a $0.53 annualized dividend and a yield of 0.86%. Agilent Technologies’s dividend payout ratio is currently 29.78%.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.